These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9143867

  • 1. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM, Cavanaugh JH, Leese P, Kasier J, Cao G, Locke CS, Dube LM.
    Eur J Clin Pharmacol; 1997; 52(1):49-54. PubMed ID: 9143867
    [Abstract] [Full Text] [Related]

  • 2. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR, Barbey JT, Franc J, Brown KS, Feirrera I, Ford N, Salazar DE.
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.
    Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK.
    J Clin Psychopharmacol; 1997 Dec; 17(6):451-9. PubMed ID: 9408807
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interactions between zileuton and prednisone.
    Awni WM, Cavanaugh JH, Tzeng TB, Witt G, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Dec; 29 Suppl 2():105-11. PubMed ID: 8620666
    [Abstract] [Full Text] [Related]

  • 5. Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
    Robbins B, Chang CT, Cramer JA, Garreffa S, Hafkin B, Hunt TL, Meligeni J.
    Clin Pharmacol Ther; 1996 Mar; 59(3):275-83. PubMed ID: 8653990
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM, Braeckman RA, Cavanaugh JH, Locke CS, Linnen PJ, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Mar; 29 Suppl 2():112-24. PubMed ID: 8620667
    [Abstract] [Full Text] [Related]

  • 7. Azithromycin and terfenadine: lack of drug interaction.
    Harris S, Hilligoss DM, Colangelo PM, Eller M, Okerholm R.
    Clin Pharmacol Ther; 1995 Sep; 58(3):310-5. PubMed ID: 7554704
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM, Hussein Z, Cavanaugh JH, Granneman GR, Dubé LM.
    Clin Pharmacokinet; 1995 Sep; 29 Suppl 2():92-7. PubMed ID: 8620677
    [Abstract] [Full Text] [Related]

  • 9. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR, Braeckman RA, Locke CS, Cavanaugh JH, Dubé LM, Awni WM.
    Clin Pharmacokinet; 1995 Sep; 29 Suppl 2():77-83. PubMed ID: 8620674
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S, Banfield C, Kantesaria B, Marino M, Clement R, Affrime M, Batra V.
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans.
    Samara E, Cavanaugh JH, Mukherjee D, Granneman GR.
    Clin Pharmacokinet; 1995 Mar; 29 Suppl 2():84-91. PubMed ID: 8620675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine.
    Stern RH, Smithers JA, Olson SC.
    J Clin Pharmacol; 1998 Aug; 38(8):753-7. PubMed ID: 9725552
    [Abstract] [Full Text] [Related]

  • 17. Lack of CYP3A inhibition effects of sertindole on terfenadine in healthy volunteers.
    Wong SL, Cao G, Mack R, Granneman GR.
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):146-51. PubMed ID: 9562230
    [Abstract] [Full Text] [Related]

  • 18. The effect of zileuton on antipyrine and indocyanine green disposition.
    St Peter JV, Braeckman RA, Granneman GR, Locke CS, Cavanaugh JH, Awni WM.
    Clin Pharmacol Ther; 1995 Mar; 57(3):299-308. PubMed ID: 7697947
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
    Liu MC, Dubé LM, Lancaster J.
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.